An alternative analysis of illicit opioid use during treatment in a randomized trial of extended-release naltrexone versus buprenorphine-naloxone: a per-protocol and completers analysis – Mitchell MM, Schwartz RP, Choo TH, Pavlicova M, O'Grady KE, Gryczynski J, Stitzer ML, Nunes EV, Rotrosen J.

December 26, 2020

BACKGROUND: The distinct pharmacological properties and clinical uses of extended-release naltrexone (XR-NTX) and sublingual buprenorphine-naloxone (BUP-NX) present challenges in analyzing patient outcomes. METHODS: We conducted a secondary analysis of… (Source: SafetyLit) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read the full article →

Reckitt Benckiser files £1bn claim against former subsidiary Indivior

December 19, 2020

Claim relates to US settlement over past marketing of opioid addiction treatment Suboxone (Source: FT.com – Drugs and Healthcare)

Read the full article →

Former Medical Director of Suboxone Manufacturer Indivior Sentenced in Connection with Drug Safety Claims

December 19, 2020

FDA OCI, Suboxone Film, Indivior, medical director, sentence, drug safety, claims, Timothy Baxter, marketing, opioid, drug, Massachusetts Medicaid, recovering addicts, misbranded drug, MassHealth, false, misleading, information, accidental, pediatric, exposure, (Source: Office of Criminal Investigations (OCI) Press Releases) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your […]

Read the full article →

Indivior Solutions Sentenced as Part of $2 Billion Resolution of False Safety Claims Concerning Suboxone

November 29, 2020

FDA OCI, Indivior, Suboxone, sentence, $2 billion restitution, false safety claims, criminal penalties marketing, false statements, health care, sales force, disbanded, Shaun Thaxter, Tim Baxter, misleading data, false data, pediatric exposure, prison sentence, CEO, MassHealth, Reckitt Benckiser, (Source: Office of Criminal Investigations (OCI) Press Releases) MedWorm Message: Have you tried our new medical search engine? […]

Read the full article →

Suboxone Manufacturer Indivior's Former Chief Executive Officer Sentenced to Jail Time in Connection with Drug Safety Claims

October 29, 2020

FDA OCI, Suboxone, CEO, Indivior, CEO, sentence, jail, drug safety claims, Shaun Thaxter, 6 months jail, misbranded drug, Suboxone Film, Reckitt Benckiser, opioid, buprenorphine, addiction treatment, false, misleading, safety information, (Source: Office of Criminal Investigations (OCI) Press Releases) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with […]

Read the full article →

Hudson Woman Pleads Guilty to Tampering with Consumer Products and Unlawfully Obtaining Controlled Substances

October 22, 2020

FDA OCI, Kristina Coleman, Hudson NH, tampering, pharmacy technician, Nashua NH, prescription delivery, missing pills, oxycodone, opioids, different sizes, different imprints, baclofen, Suboxone, theft, (Source: Office of Criminal Investigations (OCI) Press Releases) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read the full article →

Opioid Manufacturer Indivior ’s Former Global Medical Director Pleads Guilty in Connection with Drug Safety Claims

September 9, 2020

FDA OCI, opioid, Indivior, director, guilty plea, drug safety claims, Timothy BAXTER, Suboxone Film, misdemeanor, misbranded drug, top medical executive, Reckitt Benckiser Pharmaceuticals, global medical director, $600 million, criminal liability, civil liability, opioid recovery, (Source: Office of Criminal Investigations (OCI) Press Releases) MedWorm Message: Have you tried our new medical search engine? More powerful than […]

Read the full article →

Indivior Solutions Pleads Guilty to Felony Charge and Indivior Entities Agree to Pay $600 Million to Resolve Criminal and Civil Investigations as Part of DOJ ’s Largest Opioid Resolution

July 29, 2020

FDA OCI, Indivior, Suboxone, film, felony, opioid, resolution, $600 million, resolve, criminal liability, civil liability, opioid, addiction, treatment, $1.4 billion, , Reckitt Benckiser, largest, withdrawal, buprenorphine, powerful opioid, film, tablet, (Source: Office of Criminal Investigations (OCI) Press Releases) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with […]

Read the full article →

FDA: Doctors Should Discuss Opioid OD Antidote With Patients

July 25, 2020

FRIDAY, July 24, 2020 — Doctors should tell patients and caregivers about the overdose antidote naloxone when they prescribe opioid painkillers such as Percocet and OxyContin and medicines to treat opioid addiction, including buprenorphine,… (Source: Drugs.com – Pharma News)

Read the full article →

Indivior pays $600m in US opioid settlement

July 25, 2020

Resolution with justice department takes total paid over addiction treatment Suboxone to $2bn (Source: FT.com – Drugs and Healthcare) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read the full article →

← Previous Entries

Next Entries →